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apoptosis via phosphrylation of p38. Stress-induced chondrocyte apoptosis
was decreased due to inhibition of p38 MAP kinase activation when
chondrocytes were incubated with SB203580 or p38 speciﬁc siRNA trans-
fection. While, the phosphorylation of p38 MAP kinase was increased in
OA chondrocytes. From the point of our results, down regulation p38
MAP kinase activation inhibited chondrocyte death induced by heat stress.
Therefore, evaluation of the interaction between phosphorylation of p38
and chondrocyte apoptosis could be one of the keys to elucidating OA
etiology.
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Purpose: The purpose of this study was to address the question of how
subchondral bone osteoblasts (SBOs) and articular cartilage chondrocytes
(ACCs) interact with each other with respect to regulation of respective
cells’ phenotypic properties and in particular the involvement of mitogen
activated protein kinase (MAPK) signalling pathways under normal and OA
joint condition. We also endeavoured to test the inﬂuence of cross-talk
between SBOs and ACCs isolated from normal and OA joint on matrix
metalloproteinase (MMP) expression.
Methods: Tissues from the knees of OA patients and normal controls were
collected to isolate SBOs and ACCs. The cellular cross-talk of SBOs and ACCs
were studied by means of both direct and indirect co-culture systems,
which made it possible to identify the role of both membrane bound and
soluble factors. Histology, immunohistochemistry, qRT-PCR, zymography,
ELISA and western blotting were some of the techniques applied to distin-
guish the changes in the co-cultured vs. non co-cultured cells. The MAPK
signalling pathways were probed by using targeted MAPK inhibitors, and
their activity monitored by western blot analysis using phospho MAPK
speciﬁc antibodies.
Results: Our co-culture studies demonstrated that OA ACCs enhanced the
SBOs differentiation compared to normal ACCs. We demonstrated that
OA ACCs induced these phenotypic changes in the SBOs via activating an
ERK1/2 signalling pathway. The ﬁndings from this study thus provided clear
evidence that OA ACCs play an integral role in altering the SBO phenotype.
In the second study, we tested the inﬂuence of normal SBOs and OA SBOs
on ACCs phenotype changes. The results showed that OA SBOs increased
the hypertrophic gene expression in co-cultured ACCs compared to normal
SBOs, a phenotype which is considered as pathological to the health
and integrity of articular cartilage. It was observed that these phenotype
changes occurred via de-activation of p38 and activation of ERK1/2 signal-
ing pathways. These ﬁndings suggest that the pathological interaction of
OA SBOs with ACCs is mediated by cross-talking between ERK1/2 and p38
pathways, resulting in ACCs undergoing hypertrophic differentiation.
Subsequent experiments to determine the effect on MMP regulation, of
SBOs and ACCs cross-talk, revealed that co-culturing OA SBOs with ACCs
signiﬁcantly enhanced the proteolytic activity and expression of MMP-2
and MMP-9. In turn, co-culture of OA ACCs with SBOs led to abundant
MMP-2 expression in SBOs. Furthermore, we showed that the addition of
ERK1/2 and JNK inhibitors reversed the elevated MMP-2 and MMP-9 pro-
duction which otherwise resulted from the interactions of OA SBOs-ACCs.
Thus, this study has demonstrated that the altered interactions between
OA SBOs-ACCs are capable of triggering the pathological pathways leading
to degenerative changes seen in the osteoarthritic joint.
Conclusions: Our results has given clear in vitro evidence that the altered
bi-directional communication of SBOs and ACCs may play a role in OA
development and that this process was mediated by MAPK signalling
pathways. Targeting these altered interactions by the use of MAPK in-
hibitors may provide the scientiﬁc rationale for the development of novel
therapeutic strategies in the treatment and management of OA.
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Purpose: Interleukin-1β (IL1β) activity or its signaling cascade has been
implicated in the pathogenesis of a number of diseases including rheuma-
toid arthritis or osteoarthritis. Dysregulated Transforming Growth Factor
β (TGFβ) signalling is also involved in the osteoarthritis process. These
two cytokines play antagonistic roles in cartilage homeostasis and several
reports have highlighted cross-talk between these two pathways. Here,
we investigated whether IL1β interferes with TGFβ signalling in human
chondrocytes.
Methods: TGFβ1-induced gene expression was analyzed through plas-
minogen activator inhibitor 1 and p3TP-Lux induction in human articular
chondrocytes. Receptor-activated Smad (RSmad) phosphorylation, TGFβ
receptors, and Smad expression were determined by Western blotting
and real-time reverse transcription-polymerase chain reaction techniques.
Signalling pathways were investigated using speciﬁc inhibitors, messenger
RNA (mRNA) silencing, and expression vectors.
Results: IL-1β impaired TGFβ signalling through TGFβ receptor type II
(TβRII) down-regulation and Smad7 upregulation. IL-1β led to inhibition
of TGFβ1-induced gene expression and Smad2/3 phosphorylation. Interest-
ingly, TβRII overexpression restored the TGFβ response of human articular
chondrocytes. However, this effect was transient, suggesting that a sec-
ondary mechanism was responsible for the alteration of the TGFβ response
with long-term exposure to IL-1β.
IL-1β down-regulated TβRII expression at both protein and mRNA levels.
It reduced TβRII transcription by inducing Sp3 via NFκB and its binding
on core promoter at the expense of Sp1. In addition, it increased TRII
protein degradation through receptor-mediated endocytosis by lipid raft
and proteasomal pathway.
Furthermore, IL-1 strongly stimulated the expression of inhibitory Smad7.
This effect was late (after 12h of incubation with IL1). It did not require de
novo synthesis, and is dependent on NFkB pathway.
Conclusions: These ﬁndings clarify the regulatory process of IL-1β on TGFβ
pathway. The IL1β-induced-impairment of TGFβ signaling could explain the
reduced responsiveness of chondrocytes to TGFβ and therefore the cartilage
breakdown during OA. Understanding this process provides new insights
into the molecular mechanisms of osteoarthritis and may facilitate the
identiﬁcation of novel approaches for its treatment.
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Purpose: Growth and development of the musculoskeletal system is a
complex process requiring intricate controls of cellular activity. Persis-
tant environmental pollutants including ligands of the Arylhydrocarbon
Receptor (AhR) such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or
Benzo(a)pyrene (BaP, tobacco tar fraction) have been shown to elicit severe
developmental defects in rodent cartilage and bone as well as growth
retardation in humans. However, the status of AhR in cartilage is currently
unknown. We investigated AhR expression and function in growth plate
(GP) chondrocytes and assessed AhR ligands impact on cartilage processes.
Methods: GP chondrocytes were established in primary culture. Cells were
challenged with Interleukin-1beta (IL-1B) for 6 or 20 hr at concentrations
ranging from 0.05 to 2 ng/ml, then for another 20 hr with TCDD (5 nM)
or BaP at 1 μM. IL-1B and AhR target genes were analyzed by qPCR and
western blot. AhR localization was analyzed by immunocytochemistry
Results: GP chondrocytes expressed minor levels of AhR. AhR translocation
by TCDD into the nucleus required normoxia and the presence of IL-1B.
IL-1B induced AhR expression at the mRNA and protein levels and this
induction was higher (2-fold) in normoxia than hypoxia. The IL-1B effect
on AhR is transcriptional, through the AP-1 pathway.
Upon addition, IL-1B elicited a transient decrease (1h-6h) in Cyp1A1 mRNA
